Trial: 202006136

A Phase 1, Multicenter, Open-Label Study to Determine the Safety,
Tolerability, Pharmacokinetics, and Preliminary Efficacy of Combinations
of ABBV-927 with ABBV-368, Budigalimab (ABBV-181) and/or
Chemotherapy in Subjects with Locally Advanced or Metastatic Solid
Tumors

Phase

I

Principal Investigator

Opyrchal, Mateusz

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov